Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.0481M
August 31, 2025 -0.0092M
May 31, 2025 0.0221M
February 28, 2025 -0.0163M
November 30, 2024 -0.0594M
August 31, 2024 0.061M
May 31, 2024 0.0264M
February 29, 2024 -0.1177M
November 30, 2023 -0.0819M
August 31, 2023 -0.1207M
May 31, 2023 -0.0234M
February 28, 2023 -0.0599M
November 30, 2022 -0.0192M
August 31, 2022 -0.0389M
May 31, 2022 -0.019M
February 28, 2022 -0.0374M
November 30, 2021 -0.0687M
August 31, 2021 -0.1252M
Date Value
May 31, 2021 -0.1571M
February 28, 2021 -0.1395M
November 30, 2020 -0.0829M
August 31, 2020 -0.1643M
May 31, 2020 -0.1304M
February 29, 2020 -0.2658M
November 30, 2019 -0.4069M
August 31, 2019 -0.5034M
May 31, 2019 -0.6259M
February 28, 2019 -0.9137M
November 30, 2018 -0.4996M
August 31, 2018 -0.4698M
May 31, 2018 -0.4556M
February 28, 2018 -0.0792M
November 30, 2017 -0.2613M
August 31, 2017 -0.4057M
May 31, 2017 -0.2061M
February 28, 2017 -0.2394M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 1.697M
Integrated BioPharma, Inc. 0.517M
BioForce Nanosciences Holdings, Inc. -0.027M
Skinvisible, Inc. 0.0022M
Skinhealth Systems, Inc. 2.671M

Cash from Operations (Quarterly) Related Metrics